DOI: 10.1002/ccr3.9308 ISSN: 2050-0904
A case of COVID ‐19‐associated C‐ANCA vasculitis, was successfully treated with rituximab therapy
Michael Filoramo, Renish Contractor, Deepak Chandramohan, Prabhat Singh, Nihar Jena, Prathap Kumar Simhadri Key Clinical Message
Both C‐anti‐neutrophil cytoplasmic antibody (ANCA) and P‐ANCA vasculitis were reported to be associated with COVID‐19 infection. The ideal management of COVID‐19‐associated ANCA vasculitis is unclear, as the experiences were limited to case reports. We presented a case of COVID‐19‐associated C‐ANCA vasculitis, successfully treated with steroids and rituximab therapy without any significant adverse reactions.